CADTH has received the following notice(s) of pending drug submission(s).
Eli Lilly Canada Inc.
Severe hypoglycemic reactions
Call for patient input
Patient input d...
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.
We are pleased to announce that process and operational changes have been made to transition Cancer Drug Implementation Advisory Committee (CDIAC) functions to CADTH effective July 1, 2019. These changes will further enhance the transparency of the CADTH pan-Canadian Oncology Drug Review (pCODR) review process and better support public pay...